ELIGLUSTAT vs ELRANATAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ELIGLUSTAT vs ELRANATAMAB: Safety Overview
| Metric | ELIGLUSTAT | ELRANATAMAB |
|---|---|---|
| Total FAERS Reports | 1,368 | 758 |
| Deaths Reported | 18 | 177 |
| Death Rate | 1.3% | 23.4% |
| Hospitalizations | 173 | 482 |
| Average Patient Age | 48.6 yrs | 67.6 yrs |
| % Female Patients | 57.1% | 45.2% |
| FDA Approval Date | Aug 17, 2022 | N/A |
| Manufacturer | Genzyme Corporation | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |